Bladder cancer medical therapy: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) No edit summary |
||
| Line 17: | Line 17: | ||
'''Chemotherapy''' | '''Chemotherapy''' | ||
* Intravesical [[chemotherapy]]<ref>Bladder Cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/bladder/treatment/?region=ab Accessed on October, 7 2015 </ref> | * Intravesical [[chemotherapy]] | ||
:* During intravesical chemotherapy, the drugs are placed into the bladder through a urinary catheter.<ref>Bladder Cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/bladder/treatment/?region=ab Accessed on October, 7 2015 </ref> | |||
:* Intravesical chemotherapy may be given instead of BCG or if the bladder cancer doesn’t respond to BCG. | :* Intravesical chemotherapy may be given instead of BCG or if the bladder cancer doesn’t respond to BCG. | ||
:* [[Mitomycin]] is the drug most often used in intravesical chemotherapy. | :* [[Mitomycin]] is the drug most often used in intravesical chemotherapy. | ||
* Systemic chemotherapy | * Systemic chemotherapy | ||
| Line 33: | Line 33: | ||
* [[External beam radiation therapy]] is the type of radiation treatment that is most often used to treat bladder cancer. | * [[External beam radiation therapy]] is the type of radiation treatment that is most often used to treat bladder cancer. | ||
* Palliative radiation therapy may be given to relieve symptoms caused by advanced bladder cancer. | * Palliative radiation therapy may be given to relieve symptoms caused by advanced bladder cancer. | ||
==References== | ==References== | ||
Revision as of 14:20, 7 May 2018
|
Bladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bladder cancer medical therapy On the Web |
|
American Roentgen Ray Society Images of Bladder cancer medical therapy |
|
Risk calculators and risk factors for Bladder cancer medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
The predominant therapy for bladder cancer is surgical resection. Adjunctive chemotherapy, radiation therapy, and immunotherapy may be required.
Medical Therapy
Immunotherapy
- Immunotherapy is a type of biological therapy that uses the immune system to help destroy cancer cells.[1]
- Bacillus Calmette–Guérin (BCG)
- Immunotherapy by intravesicular delivery of Bacillus Calmette–Guérin (BCG) is often used to treat and prevent the recurrence of superficial tumors.[2]
- BCG is a vaccine against tuberculosis that is prepared from attenuated live Mycobacterium bovis, that has lost its virulence in humans. BCG immunotherapy is effective in up to 2/3 of the cases at this stage, and in randomized trials has been shown to be superior to standard chemotherapy.[3]
- The mechanism by which BCG prevents recurrence is unknown, but the presence of bacteria in the bladder may trigger a localized immune reaction which clears residual cancer cells.
Chemotherapy
- Intravesical chemotherapy
- Systemic chemotherapy
- During systemic chemotherapy, the drugs are given intravenously.
- Systemic chemotherapy may be a treatment option for bladder cancer that has spread to other tissues near the bladder and bladder cancer that has spread to other parts of the body.
- Chemotherapy is recommended before a radical cystectomy (called neoadjuvant chemotherapy) for many people with bladder cancer that has grown into the muscle layer of the bladder wall. It is also often given after a radical cystectomy (called adjuvant chemotherapy) to people with high-risk features such as cancer that has spread to lymph nodes.
Radiation therapy
- Radiation therapy may be the main treatment for people who can’t have surgery.[5]
- External beam radiation therapy is the type of radiation treatment that is most often used to treat bladder cancer.
- Palliative radiation therapy may be given to relieve symptoms caused by advanced bladder cancer.
References
- ↑ Ghahestani SM, Shakhssalim N (2009). "Palliative treatment of intractable hematuria in context of advanced bladder cancer: a systematic review". Urol J. 6 (3): 149–56. PMID 19711266.
- ↑ Alexandroff AB, Jackson AM, O'Donnell MA, James K (May 1999). "BCG immunotherapy of bladder cancer: 20 years on". Lancet. 353 (9165): 1689–94. doi:10.1016/S0140-6736(98)07422-4. PMID 10335805.
- ↑ Lamm, Donald L.; Blumenstein, Brent A.; Crawford, E. David; Montie, James E.; Scardino, Peter; Grossman, H. Barton; Stanisic, Thomas H.; Smith Jr, Joseph A.; Sullivan, Jerry; Sarosdy, Michael F.; Crissman, John D.; Coltman, Charles A. (1991). "A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder". New England Journal of Medicine. 325 (17): 1205–9. doi:10.1056/NEJM199110243251703. PMC 1164610. PMID 1922207.
- ↑ Bladder Cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/bladder/treatment/?region=ab Accessed on October, 7 2015
- ↑ Konski A, Feigenberg S, Chow E (April 2005). "Palliative radiation therapy". Semin. Oncol. 32 (2): 156–64. PMID 15815960.